Clinical analysis of ocular adnexal mucosa-associated lymphoid tissue lymphoma with IgG4-related ophthalmic disease

References

• Kubota T, Moritani S, Katayama M, Terasaki H. Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder. Arch Ophthalmol. 2010;128(5):577–584. doi:10.1001/archophthalmol.2010.45. PMID: 20457978.
   PubMedGoogle Scholar
• Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21–30. doi:10.1007/s10165-011-0571-z. PMID: 22218969.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22(3):414–418. doi:10.1007/s10165-011-0520-x. PMID: 21894525.
   PubMed Web of Science ®Google Scholar
• Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32(8):1159–1167. doi:10.1097/PAS.0b013e31816148ad. PMID: 18580683.
   PubMed Web of Science ®Google Scholar
• Kubota T, Moritani S, Yoshino T, Nagai H, Terasaki H. Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells. J Clin Pathol. 2010;63(12):1059–1065. doi:10.1136/jcp.2010.082156. PMID: 20980530.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Kim N, Choe J-Y, Khwarg SI, Jeon YK, Choung H-K, et al. Clinicopathological analysis of ocular adnexal extranodal marginal zone B-cell lymphoma with IgG4-positive cells. PLoS One. 2015;10(6):e0131458. doi:10.1371/journal.pone.0131458. PMID: 26111022.
   PubMed Web of Science ®Google Scholar
• Amin MB, Edge SB. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.
   Google Scholar
• Goto H, Takahira M, Azumi A. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59(1):1–7. doi:10.1007/s10384-014-0352-2. PMID: 25392273.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–3068. doi:10.1200/jco.2013.54.8800. PMID: 25113753.
   PubMed Web of Science ®Google Scholar
• Hong JW, Kang S, Song MK, Ahn CJ, Sa H-S. Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease. Br J Ophthalmol. 2018;102(11):1591–1595. doi:10.1136/bjophthalmol-2017-311519. PMID: 29420193.
   PubMed Web of Science ®Google Scholar
• Kubota T, Katayama M, Nishimura R, Moritani S. Long-term outcomes of ocular adnexal lesions in IgG4-related ophthalmic disease. Br J Ophthalmol. 2020;104(3):345–349. doi:10.1136/bjophthalmol-2018-313730. PMID: 31272957.
   PubMed Web of Science ®Google Scholar
• McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part II: clinical aspects. Ophthalmic Plast Reconstr Surg. 2015;31(3):167–178. doi:10.1097/iop.0000000000000364. PMID: 25564258.
   PubMed Web of Science ®Google Scholar
• Sa H-S, Lee J-H, Woo KI, Kim Y-D. IgG4-related disease in idiopathic sclerosing orbital inflammation. Br J Ophthalmol. 2015;99(11):1493–1497. doi:10.1136/bjophthalmol-2014-305528. PMID: 25947555.
   PubMed Web of Science ®Google Scholar
• Hindsø TG, Esmaeli B, Holm F, Mikkelsen LH, Rasmussen PK, Coupland SE, et al. International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma. Br J Ophthalmol. 2020;104(3):357–362. doi:10.1136/bjophthalmol-2019-314008. PMID: 31177189.
   PubMed Web of Science ®Google Scholar
• Kwon M, Lee JS, Lee C, Yoon DH, Sa HS. Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification. Br J Ophthalmol. 2020. doi:10.1136/bjophthalmol-2020-315875. PMID: 32327417.
   PubMed Web of Science ®Google Scholar
• Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41(12):1197–1205. doi:10.1007/s00535-006-1908-9. PMID: 17287899.
   PubMed Web of Science ®Google Scholar
• Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812–1819. doi:10.1097/PAS.0b013e3181f7266b. PMID: 21107087.
   PubMed Web of Science ®Google Scholar
• Ferreri AJ, Govi S, Ponzoni M. Marginal zone lymphomas and infectious agents. Semin Cancer Biol. 2013;23(6):431–440. doi:10.1016/j.semcancer.2013.09.004. PMID: 24090976.
   PubMed Web of Science ®Google Scholar
• Tan CL, Ong YK, Tan SY, Ng SB. IgG4-positive extranodal marginal zone lymphoma arising in Hashimoto’s thyroiditis: clinicopathological and cytogenetic features of a hitherto undescribed condition. Histopathology. 2016;68(6):931–937. doi:10.1111/his.12854. PMID: 26332259.
   PubMed Web of Science ®Google Scholar
• Kauppi M, Pukkala E, Isomäki H. Elevated incidence of hematologic malignancies in patients with Sjögren’s syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control. 1997;8(2):201–204. doi:10.1023/a:1018472213872. PMID: 9134244.
   PubMed Web of Science ®Google Scholar
• Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis. 1992;51(4):437–439. doi:10.1136/ard.51.4.437. PMID: 1586239.
   PubMed Web of Science ®Google Scholar
• Ekström K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum. 2003;48(4):963–970. doi:10.1002/art.10939. PMID: 12687538.
   PubMed Web of Science ®Google Scholar
• Tang H, Yang H, Zhang P, Wu D, Zhang S, Zhao J, et al. Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China. Sci Rep. 2020;10(1):4910. doi:10.1038/s41598-020-61585-z. PMID: 32188869.
   PubMed Web of Science ®Google Scholar
• Yen MT, Bilyk JR, Wladis EJ, Bradley EA, Mawn LA. Treatments for ocular adnexal lymphoma: a report by the american academy of ophthalmology. Ophthalmology. 2018;125(1):127–136. doi:10.1016/j.ophtha.2017.05.037. PMID: 28712656.
   PubMed Web of Science ®Google Scholar